Torrent Pharmaceuticals 52nd AGM and E-Voting Notice Published in Financial Express
NOOR MOHMMED
05/Jul/2025

-
Torrent Pharmaceuticals Limited confirms publication of its 52nd Annual General Meeting and E-Voting procedure in Financial Express.
-
Notices were issued in both English and Gujarati editions on 5th July 2025 ensuring clear shareholder communication.
-
Disclosure filed with BSE and NSE shows Torrent Pharma’s commitment to transparency and regulatory compliance.
Torrent Pharmaceuticals Limited, one of India's leading pharmaceutical companies, has formally communicated to its shareholders and the stock exchanges that it has published the statutory newspaper advertisement about its 52nd Annual General Meeting (AGM) and E-Voting Procedure.
This announcement, dated 5th July 2025, was addressed to both BSE Limited (Scrip Code: 500420) and National Stock Exchange of India Limited (Scrip Code: TORNTPHARM).
The communication demonstrates Torrent Pharma’s commitment to shareholder engagement, regulatory compliance, and transparent corporate governance.
Background on Torrent Pharmaceuticals Limited
Founded in 1972, Torrent Pharmaceuticals Limited has grown into one of India’s top pharmaceutical companies with a significant global footprint.
Key Company Details:
-
CIN: L24230GJ1972PLC002126
-
Registered Office: Torrent House, Off Ashram Road, Ahmedabad-380 009, Gujarat, India.
-
Phone: +91 79 26599000
-
Fax: +91 79 26582100
-
Website: www.torrentpharma.com
Torrent Pharma operates in over 40 countries and maintains a portfolio spanning cardiology, diabetology, gastroenterology, CNS, and antibiotics.
Purpose of the Announcement
The disclosure confirms that Torrent Pharmaceuticals Limited has published newspaper advertisements as required under Companies Act, 2013 and SEBI’s Listing Regulations, 2015.
These ads inform shareholders about:
-
The date and agenda of the 52nd Annual General Meeting.
-
Instructions for remote e-voting so shareholders can participate even if they cannot attend physically.
-
Details of e-voting timelines and cut-off dates.
-
Contact details for resolving voting-related queries.
By doing so, Torrent Pharma meets its statutory obligations to provide adequate notice to all shareholders.
Details of the Newspaper Publication
The company published the notice in Financial Express on 5th July 2025, in both:
-
English edition (widely read nationally and internationally).
-
Gujarati edition (to cater to local shareholders in Gujarat, where the company is headquartered).
This bilingual approach ensures inclusive communication, reaching all shareholder segments effectively.
Regulatory Requirements for AGM Notices
Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 mandate listed companies to:
-
Send physical or electronic notices of AGM to all shareholders.
-
Publish public notices in widely circulated newspapers in regional and English languages.
This ensures that all shareholders, including those whose contact information may not be current in records, receive adequate and timely notice.
E-Voting Procedure
E-voting is a crucial element of modern shareholder democracy.
Torrent Pharmaceuticals Limited’s notice explains:
-
Remote e-voting period start and end times.
-
Cut-off date for determining shareholder eligibility to vote.
-
User credentials and methods for logging into the e-voting portal.
-
Contact details for technical support.
This enables participation from remote locations, supporting shareholders who cannot attend the AGM in person.
Significance of the AGM
Annual General Meetings are vital corporate governance events.
During its 52nd AGM, Torrent Pharma will:
-
Present financial statements for shareholder approval.
-
Announce dividends, if any.
-
Appoint or reappoint Directors and Auditors.
-
Discuss any special business resolutions.
-
Address shareholder questions.
This forum promotes accountability, giving investors a chance to scrutinise and engage with the management.
Transparency in Corporate Governance
Torrent Pharma’s disclosure highlights its strong corporate governance framework.
By proactively:
-
Notifying the exchanges.
-
Publishing the notice in leading newspapers.
-
Providing bilingual communication.
The company demonstrates its commitment to transparency and regulatory compliance.
Such practices help build investor confidence, essential in the highly competitive pharmaceutical industry.
SEBI’s Emphasis on Investor Protection
SEBI, India’s capital markets regulator, places strong emphasis on:
-
Timely disclosures.
-
Fair and equitable treatment of all shareholders.
-
Facilitating remote participation via e-voting.
By following these norms meticulously, Torrent Pharma aligns with best-in-class governance standards, a key differentiator for global investors.
Importance of Bilingual Communication
Publishing notices in both English and Gujarati:
-
Ensures local investors in Gujarat (Torrent’s home state) are informed in their mother tongue.
-
Meets regulatory requirements for regional language communication.
-
Reflects respect for diversity and inclusivity in shareholder engagement.
This also reduces legal risks associated with inadequate notice.
Details Shared in the Filing
The letter to BSE and NSE, signed by Chintan M. Trivedi, Company Secretary, included:
-
Copies of the newspaper cuttings published on 5th July 2025.
-
Clear subject line about the AGM and e-voting procedure.
-
Assurance of compliance with all regulatory requirements.
These materials are now part of the public record, accessible to investors and analysts.
Contact Channels for Investors
Torrent Pharma provides multiple official channels for shareholders to seek clarifications:
-
Website: www.torrentpharma.com
-
Phone and Fax: Listed prominently in all communications.
These open channels demonstrate investor focus and customer service orientation.
Implications for Investors
For Torrent Pharma shareholders, this announcement:
-
Confirms the date and procedure for participating in the 52nd AGM.
-
Ensures transparent communication via newspapers.
-
Facilitates informed decision-making on AGM agenda items.
Shareholders should carefully review the AGM notice and participate in e-voting to exercise their rights effectively.
Conclusion
Torrent Pharmaceuticals Limited’s announcement about publishing its AGM and e-voting notice in Financial Express on 5th July 2025 is a strong testament to its commitment to transparency, governance, and shareholder rights.
This communication:
-
Meets statutory requirements under Companies Act and SEBI Listing Regulations.
-
Ensures inclusive reach through English and Gujarati newspapers.
-
Supports remote voting via a clear e-voting procedure.
For investors, it is an opportunity to engage meaningfully with the company’s leadership and influence its strategic direction.
As one of India’s leading pharmaceutical firms, Torrent Pharma continues to set high standards in corporate communication and governance, building long-term trust with its stakeholders.
The Upcoming IPOs in this week and coming weeks are Asston Pharmaceuticals, CFF Fluid Control, Smarten Power Systems, Glen Industries, Travel Food Services, Anthem Biosciences, Chemkart India.
The Current active IPO are Meta Infotech, Happy Square Outsourcing Services, Cryogenic OGS.
Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.
Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.